E A Egan, G Mantilla, R M Nelson, D V Eitzman. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Administration, OralClinical Trials as TopicDrug EvaluationDrug Resistance, MicrobialEnterocolitis, Pseudomembranous/prevention & controlEscherichia coliFeeding BehaviorFloridaHumansInfant, NewbornInfant, Premature, Diseases/prevention & controlIntestinal AbsorptionKanamycin/administration & dosageKanamycin/bloodProspective Studies
Substances: See more » Kanamycin
Year: 1976 PMID: 784926 DOI: 10.1016/s0022-3476(76)80553-7
Source DB: PubMed Journal: J Pediatr ISSN: 0022-3476 Impact factor: 4.406